Articles with public access mandates - Shannon E DunnLearn more
Not available anywhere: 1
Noncovalent protein arginine deiminase (PAD) inhibitors are efficacious in animal models of multiple sclerosis
EJC Tejeda, AM Bello, E Wasilewski, A Koebel, S Dunn, LP Kotra
Journal of Medicinal Chemistry 60 (21), 8876-8887, 2017
Mandates: Canadian Institutes of Health Research
Available somewhere: 28
Type II monocytes modulate T cell–mediated central nervous system autoimmune disease
MS Weber, T Prod'homme, S Youssef, SE Dunn, CD Rundle, L Lee, ...
Nature medicine 13 (8), 935-943, 2007
Mandates: German Research Foundation
PPAR-δ senses and orchestrates clearance of apoptotic cells to promote tolerance
L Mukundan, JI Odegaard, CR Morel, JE Heredia, JW Mwangi, ...
Nature medicine 15 (11), 1266-1272, 2009
Mandates: US National Institutes of Health, Howard Hughes Medical Institute
Regulation of obesity-related insulin resistance with gut anti-inflammatory agents
H Luck, S Tsai, J Chung, X Clemente-Casares, M Ghazarian, XS Revelo, ...
Cell metabolism 21 (4), 527-542, 2015
Mandates: US National Institutes of Health, Canadian Institutes of Health Research
Insulin receptor-mediated stimulation boosts T cell immunity during inflammation and infection
S Tsai, X Clemente-Casares, AC Zhou, H Lei, JJ Ahn, YT Chan, O Choi, ...
Cell metabolism 28 (6), 922-934. e4, 2018
Mandates: US National Institutes of Health, Canadian Institutes of Health Research …
Peroxisome proliferator-activated receptor (PPAR) α and-γ regulate IFNγ and IL-17A production by human T cells in a sex-specific way
MA Zhang, D Rego, M Moshkova, H Kebir, A Chruscinski, HK Nguyen, ...
Proceedings of the National Academy of Sciences 109 (24), 9505-9510, 2012
Mandates: Canadian Institutes of Health Research
Sex-specific T-cell regulation of angiotensin II–dependent hypertension
H Ji, W Zheng, X Li, J Liu, X Wu, MA Zhang, JG Umans, M Hay, RC Speth, ...
Hypertension 64 (3), 573-582, 2014
Mandates: US National Institutes of Health
Peroxisome proliferator–activated receptor δ limits the expansion of pathogenic Th cells during central nervous system autoimmunity
SE Dunn, R Bhat, DS Straus, RA Sobel, R Axtell, A Johnson, K Nguyen, ...
Journal of Experimental Medicine 207 (8), 1599-1608, 2010
Mandates: US National Institutes of Health
Statins in the treatment of central nervous system autoimmune disease
MS Weber, S Youssef, SE Dunn, T Prod'homme, O Neuhaus, O Stuve, ...
Journal of neuroimmunology 178 (1-2), 140-148, 2006
Mandates: German Research Foundation
Puberty in females enhances the risk of an outcome of multiple sclerosis in children and the development of central nervous system autoimmunity in mice
JJ Ahn, J O’Mahony, M Moshkova, HE Hanwell, H Singh, MA Zhang, ...
Multiple Sclerosis Journal 21 (6), 735-748, 2015
Mandates: Canadian Institutes of Health Research, Multiple Sclerosis Society of Canada
Antagonizing peroxisome proliferator–activated receptor α activity selectively enhances Th1 immunity in male mice
MA Zhang, JJ Ahn, FL Zhao, T Selvanantham, T Mallevaey, N Stock, ...
The Journal of Immunology 195 (11), 5189-5202, 2015
Mandates: Canadian Institutes of Health Research, Multiple Sclerosis Society of Canada
Neither T-helper type 2 nor Foxp3+regulatory T cells are necessary for therapeutic benefit of atorvastatin in treatment of central nervous system autoimmunity
MS Weber, T Prod’homme, S Youssef, SE Dunn, L Steinman, SS Zamvil
Journal of neuroinflammation 11, 1-10, 2014
Mandates: US National Institutes of Health
Voluntary wheel running reveals sex-specific nociceptive factors in murine experimental autoimmune encephalomyelitis
KA Mifflin, MS Yousuf, KC Thorburn, J Huang, ME Pérez-Muñoz, ...
Pain 160 (4), 870-881, 2019
Mandates: Canadian Institutes of Health Research, Natural Sciences and Engineering …
PPAR-delta promotes survival of chronic lymphocytic leukemia cells in energetically unfavorable conditions
YJ Li, L Sun, Y Shi, G Wang, X Wang, SE Dunn, C Iorio, RA Screaton, ...
Leukemia 31 (9), 1905-1914, 2017
Mandates: Canadian Institutes of Health Research, National Natural Science Foundation …
PPAR-delta modulates membrane cholesterol and cytokine signaling in malignant B cells
L Sun, Y Shi, G Wang, X Wang, S Zeng, SE Dunn, GD Fairn, YJ Li, ...
Leukemia 32 (1), 184-193, 2018
Mandates: Canadian Institutes of Health Research, National Natural Science Foundation …
Generation of antigen microarrays to screen for autoantibodies in heart failure and heart transplantation
A Chruscinski, FYY Huang, A Nguyen, J Lioe, LC Tumiati, S Kozuszko, ...
PloS one 11 (3), e0151224, 2016
Mandates: Heart and Stroke Foundation of Canada
OGR1/GPR68 modulates the severity of experimental autoimmune encephalomyelitis and regulates nitric oxide production by macrophages
CA D’Souza, FL Zhao, X Li, Y Xu, SE Dunn, L Zhang
PloS one 11 (2), e0148439, 2016
Mandates: US National Institutes of Health, Canadian Institutes of Health Research
Inhibitors of protein arginine deiminases and their efficacy in animal models of multiple sclerosis
A Sarswat, E Wasilewski, SK Chakka, AM Bello, AV Caprariello, ...
Bioorganic & medicinal chemistry 25 (9), 2643-2656, 2017
Mandates: Canadian Institutes of Health Research
Optimal attenuation of experimental autoimmune encephalomyelitis by intravenous immunoglobulin requires an intact interleukin-11 receptor
CA Figueiredo, PC Drohomyrecky, SDS McCarthy, D Leontyev, XZ Ma, ...
PloS one 9 (7), e101947, 2014
Mandates: Canadian Institutes of Health Research, Multiple Sclerosis Society of Canada
Peroxisome proliferator-activated receptor–δ supports the metabolic requirements of cell growth in TCRβ-selected thymocytes and peripheral CD4+ T cells
FL Zhao, JJ Ahn, ELY Chen, TJ Yi, NH Stickle, D Spaner, ...
The Journal of Immunology 201 (9), 2664-2682, 2018
Mandates: Multiple Sclerosis Society of Canada
Publication and funding information is determined automatically by a computer program